In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Start-Up Previews

Executive Summary

This Month's Profile Group: Breast Cancer Diagnostics: Start-Ups Look To Fill Gaps In The Patient Care Continuum, features profiles of Delphinus Medical Technologies, Ibris, NovaScan and Real Time Tomography. Plus these Start-Ups Across Health Care: NewGen Therapeutics, Ozics, PlantForm and PsiOxus.

You may also be interested in...



NovaScan LLC

The rates of reoperation after breast conservation therapy vary between 25 and 49%, due to the presence of tumor cells remaining in the surrounding tissue after the tumor is removed. NovaScan hopes to reduce the need for these reoperations. Its FastPath residual cancer probe is designed to identify normal, benign and malignant tissue types remaining inside the surgical cavity and in excised tissue in real time during surgery.

Real Time Tomography LLC

Real Time Tomography has developed image processing and reconstruction software for use with next-generation digital 2D and 3D breast imaging systems that allows for real-time interaction with complex data in three dimensions, and provides higher image quality and reduced data storage.

Ozics AG

Although standard bone cements are commonly used to treat vertebral compression fractures, these cements are not durable enough to remedy fractured hips. But a new class of biomaterials could dramatically change the landscape. Switzerland’s Ozics AG says its injectable and load-bearing implant provides an optimal level of biomechanical performance through a minimally invasive procedure.

Related Content

Related Companies

UsernamePublicRestriction

Register

IV003740

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel